Changes in circulating levels of calcitonin gene-related peptide and nitric oxide metabolites in septic patients during direct hemoperfusion with polymyxin B-immobilized fiber

Blood Purification

Volumn 21, Issue 3, 2003, Pages 237-243

  Shimizu, Tomoharu ^a   Hanasawa, Kazuyoshi ^a   Tani, Tohru ^a   Endo, Yoshihiro ^a   Kurumi, Yoshimasa ^a   Ikeda, Toshiaki ^a,b   Fujita, Naohiro ^a,c   Morita, Hiroyuki ^a,d   Imaizumi, Hitoshi ^a,e   Sato, Takashi ^a,f   Katayama, Hiroshi ^a,g  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c Saga Prefectural Hospital   (Japan)

^d CHUKYO HOSPITAL   (Japan)

^e SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Tenjin kai Koga Hospital   (Japan)

^g OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Calcitonin gene related peptide; Endotoxin; Hemoperfusion; Multiple organ failure; Nitric oxide metabolites; Polymyxin B immobilized fiber; Sepsis; Septic shock; Toraymyxin

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NITRIC OXIDE; POLYMYXIN B;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ENDOTOXEMIA; FEMALE; GRAM NEGATIVE INFECTION; HEMODYNAMICS; HEMOPERFUSION; HUMAN; INFORMED CONSENT; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEPSIS; STATISTICAL SIGNIFICANCE; SYNTHETIC FIBER; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

AGED; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; FEMALE; HEMODYNAMIC PROCESSES; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NITRIC OXIDE; POLYMYXIN B; SEPSIS; SEVERITY OF ILLNESS INDEX; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 12444262203     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070696     Document Type: Article

References (44)

1. Ruokonen E, Takala J, Kari A, Alhava E: Septic shock and multiple organ failure. Crit Care Med 1991;19:1146-1151.
2. Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle? Shock 1998;10:79-89.
3. Mayeux PR: Pathobiology of lipopolysaccharide. J Toxicol Environ Health 1997;51:415-435.
4. Heumann D, Glauser MP, Calandra T: Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol 1998;1:49-55.
5. Wolff SM: Monoclonal antibodies and the treatment of gram-negative bacteremia and shock. N Engl J Med 1991;324:486-488.
6. Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN, Allen IE, Berger HJ, Knatterud GL, LoBuglio AF, Smith CR, and the HA-1A Sepsis Study Group: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991;324:429-436.
7. Karima R, Matsumoto S, Higashi H, Matsushima K: The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 1999;5:123-132.
8. Hanasawa K, Tani T, Oka T, Yoshioka T, Aoki H, Endo Y, Kodama M: Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber. Prog Clin Biol Res 1988;264:337-341.
9. Hanasawa K, Tani T, Kodama M: New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber. Surg Gynecol Obstet 1989;168:323-331.
10. Aoki H, Kodama M, Tani T, Hanasawa K: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412-417.
11. Kodama M, Hanasawa K, Tani T: Blood purification for critical care medicine: Endotoxin adsorption. Ther Apher 1997;1:224-227.
12. Shoji H, Tani T, Hanasawa K, Kodama M: Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: Designing and antiendotoxin efficacy in the clinical application. Ther Apher 1998;2:3-12.
13. Tani T, Hanasawa K, Endo Y, Yoshioka T, Kodama M, Kaneko M, Uchiyama Y, Akizawa T, Takahasi K, Sugai K: Therapeutic apheresis for septic patients with organ dysfunction: Hemoperfusion using a polymyxin B immobilized column. Artif Organs 1998;22:1038-1044.
14. Kodama M, Tani T, Hanasawa K, Hirata K, Hirasawa H, Oda S, Otsuka T, Yamamoto Y, Kanesaka S, takahashi Y, Maekawa K, Waka-bayashi Y, Tamakuma S, Sugimoto T, The PMX Clinical Study Group: Treatment of sepsis by plasma endotoxin removal: Hemoperfu-sion using a polymyxin-B immobilized column. J Endoroxin Res 1997;4:293-300.
15. Palmer RM: The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis. Arch Surg 1993;128:396-401.
16. Uddman R, Edvinsson L, Ekblad E, Hakanson R, Sundler F: Calcitonin gene-related peptide (CGRP): Perivascular distribution and vasodilatory effects. Regul Pept 1986;15:1-23.
17. Joyce CD, Fiscus RR, Wang X, Dries DJ, Morris RC, Prinz RA: Calcitonin gene-related peptide levels are elevated in patients with sepsis. Surgery 1990;108:1097-1101.
18. Arnalich F, Sanchez JF, Martinez M, Jimenez M, Lopez J, Vazquez JJ, Hernanz A: Changes in plasma concentrations of vasoactive neuro-peptides in patients with sepsis and septic shock. Life Sci 1995;56:75-81.
19. Arnalich F, Hernanz A, Jimenez M, Lopez J, Tato E, Vazquez JJ, Montiel C: Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock. Regul Pept 1996;65:115-121.
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies of sepsis. Crit Care Med 1992;20:864-874.
21. Goris RJ, te Boekhorst TP, Nuytinck JK, Gim-brere JS: Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 1985;120:1109-1115.
22. Stevens LE: Gauging the severity of surgical sepsis. Arch Surg 1983;118:1190-1192.
23. Endo Y, Oka T, Hanasawa K, Yoshioka T, Tani T, Nakane Y, Kodama M: Applications of protease inhibitor to hemoperfusion and plasma exchange as a regional anticoagulant. Trans Am Soc Artif Intern Organs 1985;31:429-433.
24. Shimizu T, Tani T, Hanasawa K, Endo Y, Kodama M: The role of bacterial translocation on neutrophil activation during hemorrhagic shock. Shock 2001;16:59-63.
25. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
26. Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, Segawa K, Anai H, Takagi I, Ito A, Kamochi M, Kaizu K: Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis 2002;39:937-947.
27. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, Kanno Y, Suzuki H: Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 2001;19:361-368; discussion 368-369.
28. Nakamura T, Ebihara I, Shimada N, Koide H: Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber. Intensive Care Med 1998; 24:1272-1276.
29. Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, Ikeda T, Yagi Y, Takayama K, Amano I, Shimaoka H, Ohta M, Okahisa T, Koga N, Fujita N, Yamasa H: Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg. 2001;25:660-668.
30. Cohen J: The detection and interpretation of endotoxaemia. Intensive Care Med 2000;26:S51-S56.
31. Griffin EC, Aiyar N, Slivjak MJ, Smith EF III: Effect of endotoxicosis on plasma and tissue levels of calcitonin gene-related peptide. Circ Shock 1992;38:50-54.
32. Tang Y, Han C, Fiscus RR, Wang X: Increase of calcitonin gene-related peptide (CGRP) release and mRNA levels in endotoxic rats. Shock 1997;7:225-229.
33. Huttemeier PC, Ritter EF, Benveniste H: Cal-citonin gene-related peptide mediates hypotension and tachycardia in endotoxic rats. Am J Physiol 1993;265:H767-H769.
34. Gardiner SM, Compton AM, Bennett T: Regional hemodynamic effects of calcitonin gene-related peptide. Am J Physiol 1989;256:R332-R338.
35. McEwan JR, Benjamin N, Larkin S, Fuller RW, Dollery CT, MacIntyre I: Vasodilatation by calcitonin gene-related peptide and by substance P: A comparison of their effects on resistance and capacitance vessels of human forearms. Circulation 1988;77:1072-1080.
36. Manzini S, Perretti F, De Benedetti L, Pradelles P, Maggi CA, Geppetti P: A comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: Involvement of substance P and calcitonin gene-related peptide release. Br J Pharmacol 1989;97:303-312.
37. Varga K, Wagner JA, Bridgen DT, Kunos G: Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 1998;12:1035-1044.
38. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999;400:452-457.
39. Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A, Akashi M, Nakata M, Kitajima I, Maruyama I: Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000;470:151-155.
40. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-1477.
41. Groeneveld AB, Hartemink KJ, de Groot MC, Visser J, Thijs LG: Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock. Shock 1999;11:160-166.
42. Shieh P, Zhou M, Ornan DA, Chaudry IH, Wang P: Upregulation of inducible nitric oxide synthase and nitric oxide occurs later than the onset of the hyperdynamic response during sepsis. Shock 2000;3:325-329.
43. Tanigawa K, Bellomo R, Kellum JA, Kim YM, Zar H, Lancaster JR Jr, Pinsky MR, Ondulick B: Nitric oxide metabolism in canine sepsis: Relation to regional blood flow. J Crit Care 1999;14:186-190.
44. Lu LF, Fiscus RR: Calcitonin gene-related peptide causes long-term inhibition of contraction in rat thoracic aorta through a nitric oxide-dependent pathway. Neuropeptides 1999;33:145-154.